BACKGROUND: Antiretroviral medications have been shown to benefit neurocognition in HIV/AIDS, and neurocognitive deficits are a risk factor for poor adherence to these medications. However, little is known about the predictive pathways linking medication adherence with cognitive ability. METHODS: In the current 6-month cohort study, antiretroviral medication adherence was tracked prospectively among 91 HIV-positive adults using electronic monitoring. Comprehensive neuropsychological evaluations were performed at baseline and 6 months. RESULTS: Multivariate path analyses provided evidence that antiretroviral adherence and cognitive ability are reciprocally related, although the neurocognitive pathways of this relationship appear to vary by predictive direction. Executive function and learning/memory were most strongly predictive of levels of medication adherence achieved, whereas higher levels of adherence were predictive of relative improvements in a wide range of frontostriatal brain functions including processing speed, attention, executive functions, and motor functioning. CONCLUSIONS: These data provide evidence that cognition and adherence are reciprocally related in HIV/AIDS. In particular, executive dysfunction may play a key role in this relationship. Interventions aimed at improving or preserving executive functions could hold promise for interrupting progressive declines in adherence and neurocognitive ability in HIV/AIDS.
BACKGROUND: Antiretroviral medications have been shown to benefit neurocognition in HIV/AIDS, and neurocognitive deficits are a risk factor for poor adherence to these medications. However, little is known about the predictive pathways linking medication adherence with cognitive ability. METHODS: In the current 6-month cohort study, antiretroviral medication adherence was tracked prospectively among 91 HIV-positive adults using electronic monitoring. Comprehensive neuropsychological evaluations were performed at baseline and 6 months. RESULTS: Multivariate path analyses provided evidence that antiretroviral adherence and cognitive ability are reciprocally related, although the neurocognitive pathways of this relationship appear to vary by predictive direction. Executive function and learning/memory were most strongly predictive of levels of medication adherence achieved, whereas higher levels of adherence were predictive of relative improvements in a wide range of frontostriatal brain functions including processing speed, attention, executive functions, and motor functioning. CONCLUSIONS: These data provide evidence that cognition and adherence are reciprocally related in HIV/AIDS. In particular, executive dysfunction may play a key role in this relationship. Interventions aimed at improving or preserving executive functions could hold promise for interrupting progressive declines in adherence and neurocognitive ability in HIV/AIDS.
Authors: A L Gifford; J E Bormann; M J Shively; B C Wright; D D Richman; S A Bozzette Journal: J Acquir Immune Defic Syndr Date: 2000-04-15 Impact factor: 3.731
Authors: D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh Journal: Ann Intern Med Date: 2000-07-04 Impact factor: 25.391
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Mona N Lam; Marta Stefaniak; Bryan Zolnikov Journal: J Int Neuropsychol Soc Date: 2002-05 Impact factor: 2.892
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak Journal: Neurology Date: 2002-12-24 Impact factor: 9.910
Authors: Mario Clerici; Elena Seminari; Franco Maggiolo; Angelo Pan; Marco Migliorino; Daria Trabattoni; Francesco Castelli; Fredy Suter; Maria Luisa Fusi; Lorenzo Minoli; Giampiero Carosi; Renato Maserati Journal: AIDS Date: 2002-09-06 Impact factor: 4.177
Authors: Mark L Ettenhofer; Jessica Foley; Nina Behdin; Andrew J Levine; Steven A Castellon; Charles H Hinkin Journal: Arch Clin Neuropsychol Date: 2010-08-26 Impact factor: 2.813
Authors: Doyle E Patton; Steven Paul Woods; Donald Franklin; Jordan E Cattie; Robert K Heaton; Ann C Collier; Christina Marra; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant Journal: AIDS Behav Date: 2012-11
Authors: Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin Journal: J HIV AIDS Soc Serv Date: 2016-09-23
Authors: David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant Journal: AIDS Care Date: 2012-04-24
Authors: Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols Journal: Pediatr Infect Dis J Date: 2017-08 Impact factor: 2.129
Authors: Neco X Johnson; Maria J Marquine; Ilse Flores; Anya Umlauf; Carolyn M Baum; Alex W K Wong; Alexis C Young; Jennifer J Manly; Allen W Heinemann; Susan Magasi; Robert K Heaton Journal: J Int Neuropsychol Soc Date: 2017-06-29 Impact factor: 2.892